Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.ChemDiv and Greenebaum Cancer Center sign breast cancer pact
Under the terms of the agreement, the University of Maryland Greenebaum Cancer Center (UMGCC) will be granted access to the diverse libraries designed by Chemical Diversity (ChemDiv). In
Under the terms of the agreement, the University of Maryland Greenebaum Cancer Center (UMGCC) will be granted access to the diverse libraries designed by Chemical Diversity (ChemDiv). In
“This action by the US Patent and Trademark Office (PTO) is very important to Spectrum as it will provide US market exclusivity through 2022,” stated Dr Rajesh Shrotriya,
The study will be conducted in patients with advanced cancer who express the tumor molecular target N-cadherin. This study is the first in which Adherex will explore weekly
Compound is developing next generation biotherapeutics with its AdNectin and AdZyme technologies. AdNectins are a superior alternative to monoclonal antibodies, and AdZymes are catalytic protein antagonists. The company’s
AN-152 is a novel cytotoxic conjugate with the potential to target cancer cells that express luteinizing hormone releasing hormones (LHRH) receptors (LHRH receptor positive tumors) and thus may
The market launch of Ypsomed’s OptiClik is a major milestone for the Switzerland-based company. The product itself is the world’s first semi-disposable pen system, containing both reusable and
The award was made under the Biotechnology Center’s Strategic Growth Loan (SGL) program, which helps promising North Carolina companies succeed in the challenging startup process. Ridge Diagnostics is
Albany Molecular Research (AMRI) expects to initiate operations in Singapore in the first quarter of 2005, with the goal of providing a full range of fee-for-service chemistry technologies,
According to the filed documents, Wyeth will negotiate with individual law firms to resolve their cases using one of two models: either an expedited pay option which requires
In a statistical meta-analysis of two placebo-controlled trials, Bextra elevated the combined incidence of heart attack and stroke three-fold in coronary artery bypass graft (CABG) surgery patients. In